Deciphering the role of IGF2BP3 in early life T cell development
Deciphering the role of IGF2BP3 in early life T cell development
批准号:
10199972
负责人:
Nitya Jain
金额:
$24.86万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-22 至 2023-05-31
关键词:
AdultAntibioticsAntigensAppearanceBindingBinding ProteinsBirthBone MarrowBone Marrow CellsCD8B1 geneCellsChimera organismComplexCytoplasmic ProteinDevelopmentDiscriminationDoctor of PhilosophyEnterobacteria phage P1 Cre recombinaseEnvironmentEventExposure toFaceFamilyFetal DevelopmentFoundationsFriendsGene ExpressionGene TargetingGenesGeneticGoalsGrowthHematopoiesisHematopoieticHematopoietic stem cellsHouse miceImmuneImmune responseImmune systemImmunityInfantInsulin-Like Growth Factor IIKnockout MiceLifeLightLymphocyteMalignant NeoplasmsMessenger RNAMusNatureNeonatalNewborn InfantNutrientPhenotypePlacentaProcessProteinsRNARNA-Binding ProteinsReporterReportingResidual stateRoleSpleenT cell regulationT-Cell DevelopmentT-LymphocyteT-Lymphocyte SubsetsThymus GlandTimeTranslationsXenobioticscell typeexperimental studyfetalgut microbiotain uterointerestmicrobialmicroorganism antigenmouse modelnovelpostnatalprecursor cellprematurepreventprogramspromotertranscription factortranscriptome sequencing
中文摘要
PI/PD:Jain,Nitya博士
项目总结
免疫系统在早期生命中面临着独特的挑战。在子宫内,发育中的胎儿免疫系统必须
耐受无数的母体抗原暴露,包括营养物质和外源物质
胎盘。在出生时,新生儿仍在发育中的免疫系统突然暴露在大量
环境和微生物抗原,必须迅速形成敌友区别。早期的生活
免疫系统本身在这段时间内经历了快速和彻底的变化,这些变化是由这些抗原驱动的
指导发育和效应器的转录因子调节电路的事件和作用
特定免疫细胞类型的编程。因此,出生后紧随其后的时期代表着一种独特的
胎儿免疫细胞和出生后免疫细胞明显重叠的免疫状态。因此,人们对此非常感兴趣
在理解这些决定发育质量的发育转变背后的遗传程序时
在个体发育过程中产生免疫细胞。
在初步实验中,比较了发育中的新生儿胸腺细胞的基因表达谱
成年小鼠通过RNA-SEQ鉴定出Igf2bp3基因在生命早期高表达。这款R21的目标是
应用目的是探讨IGF2BP3在生命早期T细胞发育中的作用。使用新的鼠标模型,
我们已经生成了IGF2BP3,我们将确定IGF2BP3在个体发育和
胸腺前体细胞IGF2BP3缺失对T细胞发育和功能的影响这些
基础性研究将阐明胎儿重叠时期免疫系统的组成
和出生后免疫细胞,并努力了解在这一过渡期间的免疫反应的性质
句号。
英文摘要
PI/PD: Jain, Nitya Ph.D.
PROJECT SUMMARY
The immune system faces unique challenges in early life. In utero, the developing fetal immune system must
tolerate myriad maternal antigenic exposures including nutrients and xenobiotics that are transferred across
the placenta. At birth, the still developing immune system of the newborn is abruptly exposed to a multitude of
environmental and microbial antigens and must rapidly form a discrimination of friend from foe. The early life
immune system itself undergoes rapid and radical changes during this time that are driven by these antigenic
events and the action of transcription factor regulatory circuits directing the development and effector
programming of specific immune cell types. The period immediately after birth thus represents a unique
immune state with significant overlap of fetal and postnatally derived immune cells. Thus, there is great interest
in understanding the genetic program underlying these developmental transitions that determine quality of
immune cells being generated over ontogeny.
In preliminary experiments, a comparison of gene expression profiles of developing thymic cells from neonatal
and adult mice by RNA-seq identified the gene Igf2bp3 to be highly expressed in early life. The goal of this R21
application is to explore the role of IGF2BP3 in early life T cell development. Using novel mouse models that
we have generated, we will determine the precise expression of IGF2BP3 over ontogeny and the
consequences of deletion of IGF2BP3 in thymic precursor cells on T cell development and function. These
foundational studies will shed light on the makeup of the immune repertoire during the period of overlap of fetal
and postnatal immune cells and strive to understand the nature of immune responses during this transitional
period.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/immunohorizons.2200019
发表时间:
2022-06-22
期刊:
ImmunoHorizons
影响因子:
--
作者:
[Philpott, Jordan, Kazimierczyk, Simon, Korgaonkar, Parimal, Bordt, Evan, Zois, Jaclyn, Vasudevan, Chithirachelvi, Meng, Di, Bhatia, Ishan, Lu, Naifang, Jimena, Brittany, Porter, Caryn, Cherayil, Bobby J, Jain, Nitya]
通讯作者:
Jain, Nitya
Regulation of early life immunity by maternal microchimeric cells
-
批准号:10561696
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2022
-
负责人:Nitya Jain
-
依托单位:
Regulation of early life immunity by maternal microchimeric cells
-
批准号:10426723
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2022
-
负责人:Nitya Jain
-
依托单位:
Maternal Microbial Influences on Early-life Thymic T cell development
-
批准号:10405567
-
项目类别:
-
资助金额:$49.12万
-
财政年份:2020
-
负责人:Nitya Jain
-
依托单位:
Maternal Microbial Influences on Early-life Thymic T cell development
-
批准号:10065870
-
项目类别:
-
资助金额:$50.4万
-
财政年份:2020
-
负责人:Nitya Jain
-
依托单位:
Deciphering the role of IGF2BP3 in early life T cell development
-
批准号:10038861
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2020
-
负责人:Nitya Jain
-
依托单位:
Maternal Microbial Influences on Early-life Thymic T cell development
-
批准号:10190833
-
项目类别:
-
资助金额:$49.77万
-
财政年份:2020
-
负责人:Nitya Jain
-
依托单位:
海外基金